Press Release: Upscale of SARS-CoV-2 testing capacity in the Netherlands
Veenendaal, December 17, 2020
Today, Hamilton, MolGen, and EWC Diagnostics announce their strategic partnership to scale up SARS-CoV-2 testing capacity in the Netherlands.
Since the outbreak of the COVID-19 pandemic in Europe, demand for SARS-CoV-2 detection tests has significantly increased. In order to increase testing capacity, the Dutch government, through the Ministry of Health, Welfare and Sport, invited commercial organizations to respond to a tender
released this summer.
Please read our announcement in our joint press release in the link below (available in Dutch and English).
Joint press release (Dutch version)
Joint press release (English version)
MolGen is a global total solution provider of innovative extraction DNA/RNA technology, systems, products and kits for human and animal diagnostics, the agriculture and biotech industries. MolGen’s, systems, reagents and consumables reduce hands-on time and increase productivity while maintaining high yields and reproducibility. From sample to result, MolGen is challenging the status quo in molecular diagnostics by offering platform stand-alone systems and consumables. MolGen’s portfolio offers high-quality, adaptable, and safe workflows, which can be customised to meet customers’ specific needs.
